128 related articles for article (PubMed ID: 21525208)
1. Charged amino acid patterns of coreceptor use in the major subtypes of human immunodeficiency virus type 1.
Pramanik L; Fried U; Clevestig P; Ehrnst A
J Gen Virol; 2011 Aug; 92(Pt 8):1917-1922. PubMed ID: 21525208
[TBL] [Abstract][Full Text] [Related]
2. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
[TBL] [Abstract][Full Text] [Related]
3. Position 22 of the V3 loop is associated with HIV infectivity.
Wei XM; Xu HF; Cheng XD; Bu N; Zhou HZ
Arch Virol; 2017 Mar; 162(3):637-643. PubMed ID: 27815696
[TBL] [Abstract][Full Text] [Related]
4. Distinct molecular pathways to X4 tropism for a V3-truncated human immunodeficiency virus type 1 lead to differential coreceptor interactions and sensitivity to a CXCR4 antagonist.
Del Prete GQ; Leslie GJ; Haggarty B; Jordan AP; Romano J; Hoxie JA
J Virol; 2010 Sep; 84(17):8777-89. PubMed ID: 20573813
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.
Pollakis G; Abebe A; Kliphuis A; Chalaby MI; Bakker M; Mengistu Y; Brouwer M; Goudsmit J; Schuitemaker H; Paxton WA
J Virol; 2004 Mar; 78(6):2841-52. PubMed ID: 14990703
[TBL] [Abstract][Full Text] [Related]
6. On the Physicochemical and Structural Modifications Associated with HIV-1 Subtype B Tropism Transition.
Lamers SL; Fogel GB; Liu ES; Salemi M; McGrath MS
AIDS Res Hum Retroviruses; 2016 Aug; 32(8):829-40. PubMed ID: 27071630
[TBL] [Abstract][Full Text] [Related]
7. Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.
Jensen MA; Li FS; van 't Wout AB; Nickle DC; Shriner D; He HX; McLaughlin S; Shankarappa R; Margolick JB; Mullins JI
J Virol; 2003 Dec; 77(24):13376-88. PubMed ID: 14645592
[TBL] [Abstract][Full Text] [Related]
8. Substitution of gp120 C4 region compensates for V3 loss-of-fitness mutations in HIV-1 CRF01_AE co-receptor switching.
Yu Y; Feng Y; Zhou Z; Li K; Hu X; Liao L; Xing H; Shao Y
Emerg Microbes Infect; 2023 Dec; 12(1):e2169196. PubMed ID: 36647730
[TBL] [Abstract][Full Text] [Related]
9. APOBEC3G/F as one possible driving force for co-receptor switch of the human immunodeficiency virus-1.
Heger E; Thielen A; Gilles R; Obermeier M; Lengauer T; Kaiser R; Trapp S
Med Microbiol Immunol; 2012 Feb; 201(1):7-16. PubMed ID: 21573951
[TBL] [Abstract][Full Text] [Related]
10. Deep Sequencing of the HIV-1 env Gene Reveals Discrete X4 Lineages and Linkage Disequilibrium between X4 and R5 Viruses in the V1/V2 and V3 Variable Regions.
Zhou S; Bednar MM; Sturdevant CB; Hauser BM; Swanstrom R
J Virol; 2016 Aug; 90(16):7142-58. PubMed ID: 27226378
[TBL] [Abstract][Full Text] [Related]
11. Complex determinants in human immunodeficiency virus type 1 envelope gp120 mediate CXCR4-dependent infection of macrophages.
Ghaffari G; Tuttle DL; Briggs D; Burkhardt BR; Bhatt D; Andiman WA; Sleasman JW; Goodenow MM
J Virol; 2005 Nov; 79(21):13250-61. PubMed ID: 16227248
[TBL] [Abstract][Full Text] [Related]
12. Existence of Replication-Competent Minor Variants with Different Coreceptor Usage in Plasma from HIV-1-Infected Individuals.
Maeda Y; Takemura T; Chikata T; Kuwata T; Terasawa H; Fujimoto R; Kuse N; Akahoshi T; Murakoshi H; Tran GV; Zhang Y; Pham CH; Pham AHQ; Monde K; Sawa T; Matsushita S; Nguyen TV; Nguyen KV; Hasebe F; Yamashiro T; Takiguchi M
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295903
[TBL] [Abstract][Full Text] [Related]
13. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.
Coetzer M; Cilliers T; Ping LH; Swanstrom R; Morris L
Virology; 2006 Dec 5-20; 356(1-2):95-105. PubMed ID: 16942785
[TBL] [Abstract][Full Text] [Related]
14. A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120.
Quinlan BD; Joshi VR; Gardner MR; Ebrahimi KH; Farzan M
J Virol; 2014 Mar; 88(6):3353-8. PubMed ID: 24390333
[TBL] [Abstract][Full Text] [Related]
15. The X4 phenotype of HIV type 1 evolves from R5 in two children of mothers, carrying X4, and is not linked to transmission.
Clevestig P; Maljkovic I; Casper C; Carlenor E; Lindgren S; Navér L; Bohlin AB; Fenyö EM; Leitner T; Ehrnst A
AIDS Res Hum Retroviruses; 2005 May; 21(5):371-8. PubMed ID: 15929699
[TBL] [Abstract][Full Text] [Related]
16. Linkage of amino acid variation and evolution of human immunodeficiency virus type 1 gp120 envelope glycoprotein (subtype B) with usage of the second receptor.
Yamaguchi-Kabata Y; Yamashita M; Ohkura S; Hayami M; Miura T
J Mol Evol; 2004 Mar; 58(3):333-40. PubMed ID: 15045488
[TBL] [Abstract][Full Text] [Related]
17. The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.
Edo-Matas D; Rachinger A; Setiawan LC; Boeser-Nunnink BD; van 't Wout AB; Lemey P; Schuitemaker H
Virology; 2012 Jan; 422(1):70-80. PubMed ID: 22047989
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneous spectrum of coreceptor usage among variants within a dualtropic human immunodeficiency virus type 1 primary-isolate quasispecies.
Singh A; Collman RG
J Virol; 2000 Nov; 74(21):10229-35. PubMed ID: 11024154
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120.
Derdeyn CA; Decker JM; Sfakianos JN; Wu X; O'Brien WA; Ratner L; Kappes JC; Shaw GM; Hunter E
J Virol; 2000 Sep; 74(18):8358-67. PubMed ID: 10954535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
